Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Costs and Expenses [Abstract] | ||||
| Revenue | $ 1,076,069 | $ 1,131,791 | $ 3,060,034 | $ 3,270,476 |
| cost of product and service sold, excluding impairment of Real Estate | 846,869 | 854,122 | 2,388,544 | 2,453,405 |
| Production Related Impairments or Charges | 4,723 | 7,583 | 8,923 | 7,583 |
| General and administrative | 76,568 | 70,766 | 207,952 | 197,086 |
| Selling | 64,611 | 64,049 | 183,974 | 180,490 |
| Other expense (income) | 0 | 0 | 0 | 0 |
| Interest income | (3,578) | (4,548) | (9,969) | (14,122) |
| Total costs and expenses | 989,193 | 991,972 | 2,779,424 | 2,824,442 |
| Income before income taxes | 86,876 | 139,819 | 280,610 | 446,034 |
| Provision for income taxes | 20,323 | 33,329 | 67,157 | 107,064 |
| Net income | $ 66,553 | $ 106,490 | $ 213,453 | $ 338,970 |
| Earnings per common share: | ||||
| Basic | $ 2.62 | $ 4.01 | $ 8.31 | $ 12.60 |
| Diluted | $ 2.56 | $ 3.92 | $ 8.14 | $ 12.32 |
| Weighted Average Number of Shares Outstanding [Abstract] | ||||
| Basic | 25,431 | 26,544 | 25,699 | 26,895 |
| Diluted | 25,949 | 27,188 | 26,233 | 27,513 |
| X | ||||||||||
- Definition Cost of Product and Service Sold, excluding impairment of Real Estate No definition available.
|
| X | ||||||||||
- Definition Amount of interest income, net of the cost of borrowed funds accounted for as interest expense. No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|